Inventor
Xin Guo
Inventor
Danbury, CT, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
A61MDevices for introducing media into, or onto, the body2%
B05BSpraying apparatus2%
B23CMilling2%
B23QDetails, components, or accessories for machine tools, e.g. arrangements for copying or controlling2%
B33YAdditive manufacturing, i.e. manufacturing of three-dimensional [3d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3d printing, stereolithography or selective laser sintering2%
B82YSpecific uses or applications of nanostructures2%
PatentTitleYear
10,828,478Microneedles and methods of manufacture thereof202010,744,528Adjustable ultrasonic micro-jet nozzle array with minimal quantity lubrication202010,172,858Combination pharmaceutical compositions and uses thereof201910,131,642Aldosterone synthase inhibitors20189,890,171'Aldosterone synthase inhibitors'20189,682,141'Combination of kinase inhibitors and uses thereof'20179,295,673'Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof'20169,181,272'Aldosterone synthase inhibitors'20159,150,577'Heterocyclic compounds containing an indole core'20159,150,556'Benzimidazolone chymase inhibitors'20159,101,547'Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery'20159,073,926'Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core'20159,062,056'Aza-benzimidazolone Chymase inhibitors'20158,859,004'pH-sensitive nanoparticles for oral insulin delivery'20148,722,709'Mineralocorticoid receptor antagonists'20148,501,749'Azaquinazolinediones chymase inhibitors'20138,377,949'Quinazolinedione chymase inhibitors'20137,659,252'Transdermal delivery peptides and method of use thereof'20106,897,196'pH sensitive lipids based on ortho ester linkers, composition and method'20056,420,377'Covalent conjugates of topoisomerase I and topoisomerase II inhibitors'20026,207,673'Covalent conjugates of topoisomerase I and topoisomerase II inhibitors'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2019Based in San Diego, CA, US· patent location history
2013–2018Patents assigned to BOEHRINGER INGELHEIM INT (10)· patent assignee history
2013–2016Patents assigned to GUO XIN (9)· patent assignee history
2013–2015Patents assigned to LO HO YIN (3)· patent assignee history
2013–2015Patents assigned to MAN CHUK CHUI (3)· patent assignee history
2013–2018Based in Danbury, CT, US· patent location history
2014–2015Based in Hong Kong, CN· patent location history
2016–2019Patents assigned to INTELLIKINE LLC (3)· patent assignee history
2020Based in Atlanta, GA, US· patent location history
2020Based in Sichuan, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOEHRINGER INGELHEIM INT | 10 | 2013–2018 |
| GUO XINself | 9 | 2013–2016 |
| INTELLIKINE LLC | 3 | 2016–2019 |
| LO HO YIN | 3 | 2013–2015 |
| MAN CHUK CHUI | 3 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Danbury, CT, US | 10 | 2013–2018 |
| San Diego, California, US | 5 | 2001–2019 |
| Hong Kong, CN | 2 | 2014–2015 |
| Atlanta, Georgia, US | 1 | 2020 |
| Sichuan, CN | 1 | 2020 |